These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19269352)

  • 1. Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities.
    Gómez-Martín D; Díaz-Zamudio M; Crispín JC; Alcocer-Varela J
    Autoimmun Rev; 2009 Sep; 9(1):34-9. PubMed ID: 19269352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional repression of interleukin-2 in human systemic lupus erythematosus.
    Katsiari CG; Tsokos GC
    Autoimmun Rev; 2006 Feb; 5(2):118-21. PubMed ID: 16431340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CREM in systemic lupus erythematosus.
    Xu WD; Zhang YJ; Wang W; Li R; Pan HF; Ye DQ
    Cell Immunol; 2012; 276(1-2):10-5. PubMed ID: 22560675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of interleukin 2 in SLE T cells.
    Tenbrock K; Tsokos GC
    Int Rev Immunol; 2004; 23(3-4):333-45. PubMed ID: 15204092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus].
    Guo Q; Chen XY; Su Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1100-1104. PubMed ID: 27987522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus.
    Fan W; Liang D; Tang Y; Qu B; Cui H; Luo X; Huang X; Chen S; Higgs BW; Jallal B; Yao Y; Harley JB; Shen N
    Arthritis Rheum; 2012 Nov; 64(11):3715-25. PubMed ID: 22736314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell signaling abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Krishnan S; Tsokos GC
    Methods Mol Med; 2004; 102():31-47. PubMed ID: 15286379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm.
    Kammer GM
    J Clin Invest; 2005 Apr; 115(4):836-40. PubMed ID: 15841173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients.
    Fujii Y; Fujii K; Tanaka Y
    Autoimmun Rev; 2006 Feb; 5(2):143-4. PubMed ID: 16431347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCR zeta-chain abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Krishnan S; Warke VG; Tsokos GC
    Methods Mol Med; 2004; 102():49-72. PubMed ID: 15286380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
    Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The -180 site of the IL-2 promoter is the target of CREB/CREM binding in T cell anergy.
    Powell JD; Lerner CG; Ewoldt GR; Schwartz RH
    J Immunol; 1999 Dec; 163(12):6631-9. PubMed ID: 10586058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting the molecular mechanisms of TCR zeta chain downregulation and T cell signaling abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Juang YT; Krishnan S; Tsokos GC
    Int Rev Immunol; 2004; 23(3-4):245-63. PubMed ID: 15204087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV.
    Juang YT; Wang Y; Solomou EE; Li Y; Mawrin C; Tenbrock K; Kyttaris VC; Tsokos GC
    J Clin Invest; 2005 Apr; 115(4):996-1005. PubMed ID: 15841182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
    Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
    J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
    Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
    J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.
    Bertsias GK; Nakou M; Choulaki C; Raptopoulou A; Papadimitraki E; Goulielmos G; Kritikos H; Sidiropoulos P; Tzardi M; Kardassis D; Mamalaki C; Boumpas DT
    Arthritis Rheum; 2009 Jan; 60(1):207-18. PubMed ID: 19116915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coupling cAMP signaling to transcription in the liver: pivotal role of CREB and CREM.
    Servillo G; Della Fazia MA; Sassone-Corsi P
    Exp Cell Res; 2002 May; 275(2):143-54. PubMed ID: 11969286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2).
    Lan RY; Selmi C; Gershwin ME
    J Autoimmun; 2008 Aug; 31(1):7-12. PubMed ID: 18442895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early growth response transcription factors and the modulation of immune response: implications towards autoimmunity.
    Gómez-Martín D; Díaz-Zamudio M; Galindo-Campos M; Alcocer-Varela J
    Autoimmun Rev; 2010 Apr; 9(6):454-8. PubMed ID: 20035903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.